Creon
Pancrelipase
| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|---|---|---|---|---|---|
| 2032861 | 3004217756 | AbbVie Inc. | 1 | N | 2026-01-01 | 475 W Vaughn St Tempe AZ US 85283 |
| Registration key | Listing key |
|---|---|
| 352771 | 1552537109 |
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Pancrelipase
Elagolix
Elagolix
Adalimumab
Adalimumab
pivekimab sunirine-pvzy
foscarbidopa/foslevodopa
Adalimumab
Venetoclax
Venetoclax
Venetoclax
Venetoclax
Adalimumab
Adalimumab
Elagolix and Estradiol and Norethisterone
Beractant
Upadacitinib
Telisotuzumab Vedotin
risankizumab-rzaa
Telisotuzumab Vedotin
Risankizumab-rzaa
Risankizumab-rzaa
Adalimumab
Paricalcitol
risankizumab-rzaa
leuprolide acetate
leuprolide acetate
Upadacitinib
Upadacitinib
Upadacitinib
Ritonavir
ABBVIE INC.
AbbVie Inc.
ABBVIE INC.
ABBVIE INC.
ABBVIE INC.
ABBVIE INC.
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-09-20
2021-09-17
2021-09-17
2021-09-14
2021-09-14
2021-09-17
2021-09-17
2021-09-07
2021-09-20
2021-10-18
2021-09-17
2019-04-15
2022-12-07
2022-07-07
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-19
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18
2021-10-18